Despite the limitation of follow-up time after treatment, tumor growth inhibition and cell necrosis in the treated groups supported that PRMT5-ISO5 induced by IR was effective in improving poor prognosis in HCC patients. The gene discussed is PRMT5; the disease is hepatocellular carcinoma.